公司资料
Kenvue 股价、新闻与催化剂
- 股票代码:
- KVUE
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
18.79 USD (-2.14%)
收盘价
最后更新: 2026年8月17日
33.3B USD
市值
股价为何变动
As of Aug 17, 2026, KVUE closed down 2.14% at $18.79. No new same-company headline was identified in the current news window.
公司概览
业务概览
Kenvue is a consumer health company focused on over-the-counter and personal care brands rather than pharmaceuticals or biotech. Its portfolio is anchored by familiar household products across skin health, oral care, and self-care.
所在地与行业分类
Headquartered in the United States and listed on NYSE, Kenvue has a global consumer-health footprint. It is a consumer products company, not a biotech or medtech business.
商业模式特征
The business depends on brand strength, retail distribution, pricing power, and steady consumer demand. Investors watch revenue growth, margin discipline, and portfolio management rather than clinical or regulatory catalysts.
生物医药行业定位
Kenvue sits outside biotechnology and even outside most healthcare innovation categories. It belongs in consumer health, where brand execution and demand stability matter more than research-driven catalysts.
未来催化剂
- Kenvue’s near-term catalysts are consumer-health earnings, margin stabilization, and whether the company can keep proving the post-spin story is getting cleaner. This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile. Better execution here can matter even before a new product or trial headline lands.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。